Apimeds Pharmaceuticals US (APUS) vs Vistagen Therapeutics (VTGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Apimeds Pharmaceuticals US (APUS) has outperformed Vistagen Therapeutics (VTGN) over the past year, losing 58.8% versus a loss of 93.8%. Vistagen Therapeutics is the larger company by market cap ($11.0 million vs $10.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APUS | VTGN |
|---|---|---|
| Share price | $7.05 | $0.2471 |
| Market cap | $10.64M | $10.97M |
| 1-day change | -1.12% | -1.40% |
| YTD return | -57.01% | -62.56% |
| 1-year return | -58.77% | -93.76% |
| 5-year return | — | -99.66% |
| EPS (TTM) | $-35.63 | $-1.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $5.14 |
| 52-week low | $1.51 | $0.20 |
| Distance from 52-week high | -88.19% | -95.19% |
| Average volume | 3.36M | 12.40M |
| Shares outstanding | 1.51M | 44.38M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- APUS has outperformed VTGN by 35.0 percentage points over the past year.
APUS vs VTGN FAQ
Which is bigger, Apimeds Pharmaceuticals US or Vistagen Therapeutics?
Vistagen Therapeutics (VTGN) is larger, with a market capitalization of $10.97M compared with $10.64M for Apimeds Pharmaceuticals US (APUS).
Which stock has performed better over the past year, APUS or VTGN?
APUS returned -58.77% over the past 12 months, compared with -93.76% for VTGN (price return, excluding dividends). Past performance does not predict future results.
Are Apimeds Pharmaceuticals US and Vistagen Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.